▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2288 by analyst upside · 2026-09-28
NUTX
Nutex Health Inc.
Healthcare · Market Cap $2B · P/E 8.5x
ANALYST PRICE TARGET
+30.9%
implied upside to consensus target
Current Price $220.11
Consensus Target $288.2
Bull Target $325.0
Bear Target $200.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
4
Hold
0
Sell
0
52-Week Low $83.99
52-Week High $224.28
YTD Return +48.5%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) 8.5x
Forward P/E 10.8x
EPS (TTM) $25.80
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $847M
Profit Margin 21.2%
52-WEEK RANGE
52-Week Low $83.99
52-Week High $224.28
Current Price $220.11
Bear Target $200.0
Bull Target $325.0
● Now $220.11 ● Target $288.2
TRADING DATA
Avg Volume 151K
YTD Return +48.5%
Analyst Count 5
Consensus Buy
Upside to Target +30.9%
Last Updated 2026-09-28

ANALYST SUMMARY

Nutex Health Inc. (NUTX) is currently trading at $220.11 with a Wall Street consensus price target of $288.2, implying potential upside of 30.9% over the next 12 months. 5 analysts currently cover NUTX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $325.0, while the most cautious has a target of $200.0.

NUTX operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 48.5% year-to-date and is currently trading near the upper end of its 52-week range of $83.99 – $224.28.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for NUTX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Freedom Capital Markets - Reiterated
Buy → Buy 2026-09-25 Building track record
B. Riley Securities - Reiterated
Buy → Buy 2026-09-04 17% win rate (6 calls)
Lake Street - Reiterated
Buy → Buy 2026-08-11 27% win rate (11 calls)
B. Riley Securities ● Initiated
Buy 2026-06-26 17% win rate (6 calls)
Lake Street ● Initiated
Buy 2026-06-02 27% win rate (11 calls)
Maxim Group - Reiterated
Buy → Buy 2025-08-26 28% win rate (40 calls)
Benchmark reit
Buy → Buy 2025-07-10 Building track record
Maxim Group - Reiterated
Buy → Buy 2025-05-20 28% win rate (40 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
60
out of 100
Coverage depth
14/30
Consensus clarity
19/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →